Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Mar 5:14:901-910.
doi: 10.2147/RMHP.S300656. eCollection 2021.

The Use of Classic Hallucinogens/Psychedelics in a Therapeutic Context: Healthcare Policy Opportunities and Challenges

Rafael Guimarães Dos Santos  1   2   3 , José Carlos Bouso  1   3   4 , Juliana Mendes Rocha  1 , Giordano Novak Rossi  1 , Jaime E Hallak  1   2
Affiliations
Review

The Use of Classic Hallucinogens/Psychedelics in a Therapeutic Context: Healthcare Policy Opportunities and Challenges

Rafael Guimarães Dos Santos et al. Risk Manag Healthc Policy. .

Abstract

Psychedelics or serotonergic hallucinogens are a group of substances that share the agonism of serotonergic 5-HT2A receptors as their main mechanism of action. Its main effects include changes in perception, cognitive process, and mood. Despite being used for centuries by different cultures in ritual contexts, these substances have currently aroused the interest of science and industry for their promising antidepressant, anxiolytic, and anti-addictive effects. Considering this evidence, this article aims to explore some of the possible health policy challenges to integrate these therapeutic tools into broad and heterogeneous health systems. As a main benefit, these substances produce rapid and enduring effects with the administration of single or few doses, which could lead to new treatment possibilities for patients with severe mental disorders resistant to the usual medications. The main challenge is associated with the fact that these substances remain scheduled in most countries and are associated with social stigma related to their recreational use (especially LSD and psilocybin). This situation makes it exceedingly difficult to conduct clinical trials, although international conventions allow such research. Ethically, this could be interpreted as a violation of human rights since thousands of people are prevented from having access to possible benefits. Interestingly, ritual ayahuasca use is more acceptable to the public than the use of psilocybin-containing mushrooms or LSD. The controlled, clinical use of LSD and psilocybin seems to be less criticized and is being explored by the industry. Rigorous scientific evidence coupled with industrial interests (LSD and psilocybin), together with respect for traditional uses (ayahuasca) and international conventions, seems to be the best way for these drugs to be integrated into health systems in the next years. Which highlights the need for an urgent dialogue between science, health system, society, and politics.

Keywords: hallucinogens; healthcare; psychedelics.

PubMed Disclaimer

Conflict of interest statement

GNR received funding from Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq, Brazil). JMR received funding from FAPESP (Fundação de Amparo à Pesquisa do Estado de São Paulo, Brazil). RGS is Fellow of the Programa Nacional de Pós-Doutorado, Brazil (PNPD/CAPES). JEH is recipient of Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq, Brazil) 1A productivity fellowship. The authors declare no other conflicts of interest.

References

    1. Nichols DE. Psychedelics. Pharmacol Rev. 2016;68(2):64–355. doi:10.1124/pr.115.011478 - DOI - PMC - PubMed
    1. Nichols DE. Hallucinogens. Pharmacol Ther. 2004;101(2):131–181. - PubMed
    1. Escobar JÁ, Roazzi A. Panorama contemporâneo do uso terapêutico de substâncias psicodélicas: ayahuasca e psilocibina. Neurobiologia. 2010;73(3):159–172.
    1. Grispoon L, Bakalar JB. Psychedelic Drugs Reconsidered. New York: Basic Books; 1979.
    1. Schultes RE, Hofmann A. Plants of the Gods: Their Sacred, Healing, and Hallucinogenic Powers. Rochester: Healing Arts Press; 1992.